AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CIG Pannonia Life Insurance Plc.

Board/Management Information Nov 30, 2025

2011_rns_2025-11-30_7ff65615-465b-4f7f-b894-2fa17a12c989.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

EXTRAORDINARY INFORMATION

on the resignation of a senior person

The Managing Board of CIG Pannonia Life Insurance Plc. (headquarters: H-1097 Budapest, Könyves Kálmán boulevard 11.B, company registration nr.: 01 10 045857, hereinafter referred as Company) compliance with its obligation set forth in Section 55 (1) of Act CXX of 2001 on the Capital Market and in the relevant provisions of Decree 24/2008. (VIII. 15.) PM hereby informs the Esteemed Investors and other capital market participants that Dr. Péter Bogdánffy, member and chairman of the Company's board of directors, as well as member of CIG Pannónia Első Magyar Általános Biztosító Zrt. (collectively: Companies), informed these governing bodies on November 28, 2025 that he would resign from his position as a member of the board of directors of the aforementioned companies as of November 30, 2025.

The Boards of Directors of the Companies regretfully acknowledged the above decision, but understand the reasons beyond the Companies' control. They would like to take this opportunity to thank Dr. Péter Bogdánffy for his outstanding contribution to the Companies' recent achievements, with particular regard to his personal added value in certain phases of the conclusion of the so-called Italian cases1, which was also reflected in our recent results2.

CIG Pannonia Life Insurance Plc.

Board of Directors

2

1 Italian cases: summary of existing and potential risks in EMABIT's Italian claims and their management, primarily covering the strategy for handling these cases and ongoing legal proceedings, the status and review of existing claims provisions and recourse provisions

Talk to a Data Expert

Have a question? We'll get back to you promptly.